logo
Nuclear Winter Would Be Even Worse Than We Thought

Nuclear Winter Would Be Even Worse Than We Thought

Gizmodo2 days ago
Despite happening (thankfully) just once in real life, nuclear warfare has long been a staple element of science fiction. Popular depictions of nuclear conflict—from biographic thrillers like Oppenheimer to imagined disasters like The Day After—reflect the understanding that its consequences would be irreversible and catastrophic to modern society.
Unsurprisingly, nuclear warfare and its potential repercussions concern scientists as much as fiction writers. In a recent paper published in Environmental Research Letters, researchers at Pennsylvania State University examined how nuclear war might disrupt food security worldwide, focusing specifically on the global production of corn, the most produced grain crop in the world. In the worst-case scenario, nuclear weapons would wreak havoc on our atmospheric systems, gradually cutting our annual corn production by up to 87%, the study warns.
For their simulations, the authors considered 38,572 locations for corn production across six different nuclear war scenarios of increasing severity. The simulations took place under nuclear winter conditions, a hypothetical climate scenario following a large-scale nuclear war. During nuclear winters, black carbon from fires triggered by nuclear detonations would fill up the sky, obstructing sunlight. The resulting drop in global temperatures could last for over a decade—long enough to decimate agricultural systems worldwide, according to the scientists.
In addition to black carbon, the authors examined the potential UV-B radiation exposure to plants. The Earth's ozone usually blocks this type of radiation, but this protective layer would be weakened in the wake of nuclear war. As UV-B radiation causes DNA damage and obstructs plant photosynthesis, the researchers modeled how overexposure to this energy source could affect the soil-plant-atmosphere system that drives crop growth.
The results were disturbing. First, the 'best-case scenario,' a regional nuclear war, would release enough soot into the atmosphere to reduce annual corn production by 7%—which, to be clear, would severely impact the global food system, study lead author and meteorologist Yuning Shi explained in a press release. A global-scale war, on the other hand, would inject a massive 165 million tons of soot into the atmosphere, curbing global corn production by a whopping 80%.
That wasn't all; radiation damage 'would peak in years 8 and 9' following the initial detonation of the bomb, causing an additional 7% decrease in corn yields, according to the paper. 'The blast and fireball of atomic explosions produce nitrogen oxides in the stratosphere,' Shi explained. This, in combination with heat-absorbing soot, injects a fiery cycle into the atmosphere that 'rapidly [destroys] ozone, increasing UV-B radiation levels at the Earth's surface.'
Thankfully, these are just simulations. They nevertheless 'force us to realize the fragility of the biosphere—the totality of all living things and how they interact with one another and the environment,' Shi said. What's more, the study acts as an early precursor to a more refined, effective response plan for potential disasters, he added.
Hopefully, that disaster won't be nuclear—though it could be something like a volcanic eruption, which obstructs sunlight in a similar way and is something we can better prepare for. For example, the paper recommended preparing 'agricultural resilience kits' containing seeds for crops that can grow under cooler conditions.
'These kits would help sustain food production during the unstable years following a nuclear war, while supply chains and infrastructure recover,' said Armen Kemanian, an environmental systems expert and paper senior author, in the same release. But these kits could easily assist food security in areas affected by severe volcanic activity, he added.
Natural disasters are beyond our control, save for the preparatory part. A self-inflicted environmental catastrophe and global-scale famine—that's clearly another story. When it comes to nuclear winter, the 'best approach to preventing its devastating effects is to avoid it,' the scientists wrote.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms

Associated Press

timean hour ago

  • Associated Press

Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms

Reduce development timelines and costs, while improving access to life-saving treatments VANCOUVER, BC / ACCESS Newswire / July 30, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ('Onco' or the 'Company') is pleased to announce that its wholly owned subsidiary, Inka Health Corp. ('Inka Health'), has been selected by OneMedNet Corporation (Nasdaq:ONMD) to lead a high-impact data analytics initiative focused on improving how cancer therapies are brought to market. The project focuses on leveraging OneMedNet's regulatory-grade patient data including Radiology Imaging data to develop external control arms (ECAs), which has the potential to be a faster, more cost-effective alternative to traditional clinical trials. This approach offers a potentially smarter way to generate clinical evidence by leveraging existing patient data, thereby possibly accelerating treatment access and reducing the need for costly, time-consuming trials. The initiative also provides both organizations with exposure to the rapidly expanding Real-World Evidence (RWE) market is projected to exceed $4.6 billion1 globally by 2030. This strategic project reflects growing momentum behind real-world data (RWD) as a critical component of next-generation evidence generation for cancer therapeutics2. OneMedNet's iRWDTM Real-World Data platform and federated provider network offers regulatory-grade, diverse, and longitudinal datasets, making it uniquely suited to drive Real-World Evidence (RWE) studies and accelerate healthcare innovation. The multi-phase project is intended to showcase how OneMedNet's oncology dataset can be used to replicate the results of traditional clinical trials, without the same time, cost, and complexity as traditional trials. By offering a faster and more efficient path to generate the evidence needed for regulatory and reimbursement approvals, this initiative can potentially help accelerate market entry for new cancer therapies, particularly in areas of high unmet needs like colorectal cancer. Inka Health plans to deploy its proprietary SynoGraph platform, which combines machine learning with causal inference methods, to build and validate an ECA for the Keynote-189 trial3 of pembrolizumab in non-small cell lung cancer aligned with regulatory and Health Technology Assessment (HTA) best practices, including those from the FDA, European Medicines Agency (EMA), and National Institute for Health and Care Excellence (NICE). The initial focus will be on non-small cell lung cancer (NSCLC), a prevalent and clinically significant cancer type where real-world insights can meaningfully improve both patient access to therapies and regulatory confidence. We selected Inka Health for this initiative because their methodological approach aligns perfectly with our vision for high-quality evidence generation,' said Aaron Green, President & CEO of OneMedNet. 'Their ability to apply rigorous, AI-driven analytics to our regulatory-grade, diverse datasets makes them the ideal partner to showcase how OneMedNet's Real-World Data can be used as a trusted external control arm in oncology research-with the potential to help pharmaceutical companies realize a stronger ROI on clinical development and driving broader adoption among CROs and life sciences organizations looking for faster, more cost-effective trial alternatives. The collaboration is expected to result in a scientific abstract for submission to ISPOR Europe 2025, reinforcing Inka Health's leadership in applying artificial intelligence and real-world data to oncology research. As ECAs become increasingly prominent in global drug development strategies, this project positions Onco and its subsidiary at the forefront of how industry brings new therapies to patients. 'This collaboration is about more than applying advanced analytics to oncology data. It's about reshaping how we generate credible evidence for regulatory and reimbursement decisions using real-world patients, not just trial participants. With SynoGraph, we're aiming to set a new bar for how external control arms can be built and trusted.' said Paul Arora, Co-Founder of Inka Health. Furthermore, the Company announces, further to its news releases dated May 26, 2025 and March 25, 2025, that it has extended the term of its engagement with MCS Market Communication Service GmbH (business address: Rheinpromenade 13, 40789 Monheim am Rhein, Nordrhein-Westfalen, Deutschland, email: [email protected]; telephone: +491772481220; and website: ) ('MCS') for the continued provision of a range of online marketing services, including campaign creation, production of marketing materials, as well as research and analytics (the 'Services'). The Services are expected to run until October 30, or until budget exhaustion. The Company has paid MCS EUR 250,000 for the extended term. No securities have been provided to MCS or its principals as compensation. The Services will be executed via digital channels, including Google Ads and native advertising. About OneMedNet OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD™ platform. This isn't just data, it's the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption. Beyond healthcare OneMedNet's proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities, rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at About Inka Health Inka Health is an AI-driven analytics company revolutionizing oncology research and drug development through advanced causal AI. Its proprietary platform, SynoGraph, leverages AI-powered causal inference to identify which cancer patients are most likely to respond to specific treatments, advancing precision medicine. By integrating diverse multimodal medical data-including genomics, transcriptomics, and proteomics-SynoGraph uncovers hidden insights that can optimize treatment decisions and clinical trial design. With this cutting-edge technology, Inka Health aims to help pharmaceutical companies accelerate drug development, reduce trial failures, and bring life-saving therapies to market faster. About Onco-Innovations Limited Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to pursue the prevention and treatment of cancer through pioneering research and innovative solutions. The company has secured an exclusive worldwide license to patented technology that targets solid tumours. ON BEHALF OF ONCO-INNOVATIONS LIMITED, 'Thomas O'Shaughnessy' Chief Executive Officer For more information, please contact: Thomas O'Shaughnessy Chief Executive Officer Tel: + 1 888 261 8055 [email protected] OneMedNet Contacts: Michael Wong, VP Marketing Email: [email protected] Forward-Looking Statements Caution. This news release contains forward-looking statements, including in relation to the Company's ability to collaborate successfully with OneMedNet, and the prospects of the Company, and the Company's business and plans generally, and other statements that are not historical facts. Forward-looking statements are often identified by terms such as 'will', 'may', 'potential', 'should', 'anticipate', 'expects' and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including, but not limited to, the inability of Inka or the Company to collaborate successfully with OneMedNet. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law. 1 Real World Evidence Solutions Market - 2 Wang X, Dormont F, Lorenzato C, et al. Current perspectives for external control arms in oncology clinical trials: Analysis of EMA approvals 2016-2021. J Cancer Policy. 2023;35:100403. 3 SOURCE: Onco-Innovations Limited press release

Energy company strikes deal to deliver next-gen nuclear power to critical US military base: 'We are honored'
Energy company strikes deal to deliver next-gen nuclear power to critical US military base: 'We are honored'

Yahoo

time2 hours ago

  • Yahoo

Energy company strikes deal to deliver next-gen nuclear power to critical US military base: 'We are honored'

Energy company strikes deal to deliver next-gen nuclear power to critical US military base: 'We are honored' Oklo Inc. has been selected to deliver carbon-free power to Eielson Air Force Base in Alaska through its advanced fission technology, according to Business Wire. At the heart of this project is the Aurora powerhouse, Oklo's first fast reactor technology. Unlike traditional reactors, fast reactors can efficiently utilize nuclear fuel and even recycle nuclear waste into usable energy. This represents substantial progress in sustainability and energy efficiency. Fission energy is generated when uranium or plutonium atoms are split. This process produces large amounts of heat, which can be converted into electricity. Unlike fossil fuels, fission does not emit carbon dioxide or other greenhouse gases during operation, making it a valuable energy source for combating rising global temperatures. "We are honored to support national defense resilience objectives while demonstrating the value of U.S.-pioneered fast reactor technology," Oklo co-founder and CEO Jacob DeWitte said in a statement. The implications of this stretch far beyond the Air Force base. By providing stable, long-term pricing under a power purchase agreement, Oklo's reactors could help cities and individuals avoid spending a fortune on traditional energy sources. Small, self-sustainable reactors offer a decentralized energy solution that can keep hospitals, data centers, and neighborhoods powered during outages. Oklo is designing, constructing, owning, and operating the power plant. If this project were to be executed in other areas, it would enable communities to adopt clean power without incurring expenses for infrastructure. That said, nuclear does not come without downsides. Many experts point to the high cost and longer construction times of getting nuclear online compared to solar and wind, and the Union of Concerned Scientists has regularly aired reservations about relying on lightly tested small modular reactor generation in particular. In a post last year called "Five Things the 'Nuclear Bros' Don't Want You to Know," UCS Director of Nuclear Power Safety Edwin Lyman wrote of SMRs that "it is essential to have a realistic understanding of their costs and risks," mentioning Oklo directly at times. Setting aside the difference in safety with these smaller reactors, there is nuclear waste created either way, which must be contained and stored carefully, and any water that comes into contact may contain radioactive isotopes such as tritium. But as North Carolina State University associate professor Robert B. Hayes has said, scientific data suggests that nuclear is overall much safer for human health and responsible for fewer deaths than fossil fuel sources such as coal. And while there is some greenhouse gas pollution associated with the nuclear industry as a whole, especially for mining, it does not contribute nearly as much to atmospheric pollution as dirty energy sources, making transitions toward nuclear still stand as cleaner environmental choices on the whole. Would you feel safe living close to a nuclear power plant? Absolutely It's not my first choice Depends on how close No way Click your choice to see results and speak your mind. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store